Form 4: New Enterprise Associates 16, L.P. Acquires Warrants in NeueHealth, Inc.
SEC Form 4
New Enterprise Associates 16, L.P. reports acquisition of warrants in NeueHealth, Inc. following a warrantholders agreement.
Summary
- New Enterprise Associates 16, L.P. filed a Form 4 disclosing changes in beneficial ownership of NeueHealth, Inc. securities.
- The report details the acquisition of warrants to purchase 123,729 shares of common stock at an exercise price of $0.01 on April 8, 2024.
- The warrants are issued pursuant to a Warrantholders Agreement dated April 8, 2024, and a Credit Agreement as amended.
- The warrants become exercisable after the closing date, which is the first business day following the 10-day period after the distribution of a letter to shareholders as required by the NYSE Listed Company Manual.
- The warrants expire five years after the closing date.
- The filing also identifies NEA Partners 16, L.P., NEA 16 GP, LLC, and individual managers as indirect holders, who disclaim beneficial ownership except to the extent of their pecuniary interest.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing detailing a transaction. The acquisition of warrants could be seen as a slightly positive signal, but it's not definitively bullish.
Positives
- The acquisition of warrants by a significant investor like New Enterprise Associates 16, L.P. could be seen as a positive signal for NeueHealth, Inc.
Future Outlook
The warrants are exercisable at any time after the closing date and prior to the close of business on the fifth anniversary of the Closing Date.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders and significant shareholders. This filing indicates investment activity by a major investment firm in NeueHealth, Inc.
Stakeholder Impact
- The acquisition of warrants by New Enterprise Associates 16, L.P. could potentially increase investor confidence in NeueHealth, Inc.
Key Dates
| Date | Description |
|---|---|
| 08/04/2023 | Date of the Credit Agreement between the Issuer and the lenders thereto. |
| 10/02/2023 | Date of Incremental Amendment No. 1 to the Credit Agreement. |
| 04/08/2024 | Date of Transaction, Warrantholders Agreement, and Incremental Amendment No. 2 to the Credit Agreement. |
| 04/10/2024 | Date of filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.